Ann: Appendix 4E and 2017 Annual Report, page-2

Well that's not good for Nick and JHL, I just landed and I saw this report. Revenue down 14%, if the impairment of 2016 is excluded for like for like comparison JHL has blown out losses by over 40%. and that's with re-structuring program to improve on the current situation. I think there's going to be more restructuring ! and share price continues to downslide at .019

What has happened to half of the company ?– their were 4 business units, Jayex, Appointuit, Bluepoint and P2U ? where has Bluepoint and P2 U disappeared to ? That was the big IP they apparently had and P2U was going to change the pharmacy model but they don't seem to be part of JHL anymore? Its going to be another tough year with such a limited view.